infusionsvæske

DRUG6 trials

Conditions

Acute critical illness requiring intensive care unit admission.PainPost-COVID-19 Postural Orthostatic Tachycardia SyndromePrimary hyperparathyroidismStaphylococcus aureus bacteremiaperitonitis

Phase 1

Intraperitoneal treatment with fosfomycin, metronidazole and recombinant human granulocyte-macrophage colony-stimulating factor in patients with multi-quadrant peritonitis undergoing abdominal surgery: A randomized placebo-controlled trial (TRIPLE)

Not yet recruitingCTIS2024-520317-49-02

Region Sjaelland, Reponex Pharmaceuticals A/Speritonitis

Target: 32Updated: 2026-01-12

Phase 2

A randomized, double-blind crossover study to investigate the analgesic efficacy of the bradykinin (B2) antagonist icatibant for propofol injection pain in healthy adult participants.

Not yet recruitingCTIS2025-521354-42-00

Oslo University Hospital HFPain

Target: 26Updated: 2025-08-14

Phase 3

Bisphosphonate vs. Placebo Prior to Parathyroidectomy in Primary Hyperparathyroidisme: A Randomized, blinded Placebo-controlled Trial

RecruitingCTIS2024-520073-13-00

Region MidtjyllandPrimary hyperparathyroidism

Start: 2025-03-02Target: 140Updated: 2025-06-03

Double-blind, Randomized, Placebo-controlled Phase 3 study Evaluating Efficacy and Safety of IgPro20 (subcutaneous immunoglobulin, HIZENTRA®) in post-COVID-19 Postural Orthostatic Tachycardia Syndrome (POTS)

CompletedCTIS2023-508744-22-00

CSL Behring LLCPost-COVID-19 Postural Orthostatic Tachycardia Syndrome

End: 2025-05-13Target: 17Updated: 2025-05-08

Phase 4

Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia: A randomized, non-blinded, non-inferiority interventional study

RecruitingCTIS2024-519186-21-01

Hvidovre HospitalStaphylococcus aureus bacteremia

Start: 2025-01-30Target: 264Updated: 2025-11-17

The Intensive Care Platform Trial (INCEPT)

RecruitingCTIS2024-516208-41-00

RigshospitaletAcute critical illness requiring intensive care unit admission.